Bram Verstockt (B Verstockt)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 61

Top Venues

Journal of Crohn's & colitis

Alimentary pharmacology & therapeutics

Gut

Expert review of gastroenterology & hepatology

KU Leuven

KU Leuven (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KU Leuven Sep 5o 2019

Belgium

Postdoctoral researcher :: TARGID - IBD Unit

Education History

KU Leuven

Belgium

MSC

Publications

Bram Verstockt, Sare Verstockt, Jonathan Cremer, João Sabino, Marc Ferrante, Severine Vermeire, Padhmanand Sudhakar
Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD. BMJ open gastroenterology 10 (1) (2023)
Pauline Riviere, Gabriele Bislenghi, Nassim Hammoudi, Bram Verstockt, Steven Brown, Melissa Oliveira-Cunha, Willem Bemelman, Gianluca Pellino, Paulo Gustavo Kotze, null null, Marc Ferrante, Yves Panis
Results of the Eighth Scientific Workshop of ECCO: Pathophysiology and risk factors of postoperative Crohn's disease recurrence after an ileocolic resection. Journal of Crohn's & colitis (2023)
Nathalie Van den Berghe, Dahham Alsoud, Bram Verstockt, Séverine Vermeire, Paul Declerck, Debby Thomas
Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease. Therapeutic advances in gastroenterology 16 (2023)
Dahham Alsoud, Jessica Ho, Bram Verstockt
The Serum-Based Endoscopic Healing Index Can Monitor Therapeutic Response in Crohn's Disease. Journal of Crohn's & colitis (2023)
Bram Verstockt, Sare Verstockt, Jonathan Cremer, João Sabino, Marc Ferrante, Severine Vermeire, Padhmanand Sudhakar
Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD. BMJ open gastroenterology 10 (1) (2023)
Bram Verstockt, Maaike Vancamelbeke, Severine Vermeire
Increased inflammatory state in IBD multiplex first-degree relatives not developing intestinal disease. Gut (2023)
Dahham Alsoud, Jessica Ho, João Sabino, Marc Ferrante, Séverine Vermeire, Bram Verstockt
Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis. The American journal of gastroenterology (2023)
Sudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, Tim Raine, Nurulamin M Noor, Neeraj Narula, Bram Verstockt, Brian G Feagan, Siddharth Singh, Christopher Ma, Vipul Jairath
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis. Inflammatory bowel diseases (2023)
Bram Verstockt, Lieven Pouillon, Florence Ballaux, Celine Jorissen, Eveline Hoefkens, Nikki Lembrechts, Peter Bossuyt
Patient reported outcomes and disability are associated with histological disease activity in patients with ulcerative colitis: results from the APOLLO study. Journal of Crohn's & colitis (2023)
Bram Verstockt, Lieven Pouillon, Florence Ballaux, Celine Jorissen, Eveline Hoefkens, Nikki Lembrechts, Peter Bossuyt
Patient reported outcomes and disability are associated with histological disease activity in patients with ulcerative colitis: results from the APOLLO study. Journal of Crohn's & colitis (2023)
Bram Verstockt, Valerie Pivorunas, Naim Al Mahi, Nizar Smaoui, Heath Guay, Nicholas A Kennedy, James R Goodhand, Simeng Lin, Benjamin Y H Bai, Stephen B Hanauer, Marc Ferrante, Julian Panés, Séverine Vermeire
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies. Journal of Crohn's & colitis (2023)
Pieter Sinonquel, Alessandro Schilirò, Bram Verstockt, Severine Vermeire, Raf Bisschops
Evaluating the potential of artificial intelligence in ulcerative colitis. Expert review of gastroenterology & hepatology (2023)
Markus Tschurtschenthaler, Bram Verstockt
Targeting a Hallmark of Crohn's Disease: Browning of the Hypertrophic Mesenteric Adipose Tissue as a Novel Strategy to Reduce Inflammation? Journal of Crohn's & colitis (2023)
Pieter Sinonquel, Alessandro Schilirò, Bram Verstockt, Severine Vermeire, Raf Bisschops
Evaluating the potential of artificial intelligence in ulcerative colitis. Expert review of gastroenterology & hepatology 17 (2) (2023)
Bram Verstockt, Sare Verstockt, Jonathan Cremer, João Sabino, Marc Ferrante, Severine Vermeire, Padhmanand Sudhakar
Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD. BMJ open gastroenterology 10 (1) (2023)
Pieter Sinonquel, Alessandro Schilirò, Bram Verstockt, Severine Vermeire, Raf Bisschops
Evaluating the potential of artificial intelligence in ulcerative colitis. Expert review of gastroenterology & hepatology 17 (2) (2023)
Pieter Sinonquel, Alessandro Schilirò, Bram Verstockt, Severine Vermeire, Raf Bisschops
Evaluating the potential of artificial intelligence in ulcerative colitis. Expert review of gastroenterology & hepatology (2023)
Matthias Lenfant, Bram Verstockt, João Sabino, Severine Vermeire, Marc Ferrante
The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis. Alimentary pharmacology & therapeutics (2023)
Davide Giuseppe Ribaldone, Giulia Testa, Bram Verstockt, Tamas Molnar, Edoardo Vincenzo Savarino, Carsten Schmidt, Sophie Vieujean, Niels Teich, Corina Meianu, Pascal Juillerat, Nathan Grellier, Triana Lobaton
Treatment of antibiotic refractory chronic pouchitis with JAK inhibitors and S1P receptor modulators: an ECCO CONFER Multicentre Case Series. Journal of Crohn's & colitis (2023)
Bram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, Rebecca A Mosig, Brian G Feagan, Jean-Frederic Colombel, Britta Siegmund, Florian Rieder, Stefan Schreiber, Andres Yarur, Remo Panaccione, Marla Dubinsky, Simon Lichtiger, Fabio Cataldi, Silvio Danese
The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study. Journal of Crohn's & colitis (2023)
Tim Raine, Bram Verstockt, Uri Kopylov, Konstantinos Karmiris, Rimma Goldberg, Raja Atreya, Burisch J, John Burke, Pierre Ellul, Charlotte Rose Hedin, Stefan D Holubar, Konstantinos Katsanos, Triana Lobaton, Carsten Schmidt, Garret Cullen
ECCO Topical Review: Refractory Inflammatory Bowel Disease. Journal of Crohn's & colitis 15 (10) (2022)
Kaline Arnauts, Padhmanand Sudhakar, Sare Verstockt, Cynthia Lapierre, Selina Potche, Clara Caenepeel, Bram Verstockt, Jeroen Raes, Severine Vermeire, João Sabino, Catherine M Verfaillie, Marc Ferrante
Microbiota, not host origin drives ex vivo intestinal epithelial responses. Gut microbes 14 (1) (2022)
Padhmanand Sudhakar, Dahham Alsoud, Judith Wellens, Sare Verstockt, Kaline Arnauts, Bram Verstockt, Severine Vermeire
Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All. Journal of Crohn's & colitis 16 (8) (2022)
Dotan Yogev, Bram Verstockt, Axel Dignass, Gili Focht, Ohad Atia, Iris Dotan, Severine Vermeire, Dan Turner
The Modified Mucosal Inflammation Noninvasive Index and Endoscopic Remission in Adults With Crohn's Disease. Inflammatory bowel diseases (2022)
An Outtier, Liese Gijbels, Maja Noman, Bram Verstockt, João Sabino, Séverine Vermeire, Marc Ferrante
Screening Failure in a Large Clinical Trial Centre for Inflammatory Bowel Diseases: Rates, Causes, and Outcomes. Inflammatory bowel diseases (2022)
Martina Poletti, Agatha Treveil, Luca Csabai, Leila Gul, Dezso Modos, Matthew Madgwick, Marton Olbei, Balazs Bohar, Alberto Valdeolivas, Denes Turei, Bram Verstockt, Sergio Triana, Theodore Alexandrov, Julio Saez-Rodriguez, Megan L Stanifer, Steeve Boulant, Tamas Korcsmaros
Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways. NPJ systems biology and applications 8 (1) (2022)
Dahham Alsoud, Gert De Hertogh, Griet Compernolle, Sophie Tops, João Sabino, Marc Ferrante, Debby Thomas, Severine Vermeire, Bram Verstockt
Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis. Journal of Crohn's & colitis 16 (10) (2022)
Johanne Brooks-Warburton, Dezső Módos, Padhmanand Sudhakar, Matthew Madgwick, John P Thomas, Balazs Bohar, David Fazekas, Azedine Zoufir, Orsolya Kapuy, Mate Szalay-Beko, Bram Verstockt, Lindsay J Hall, Alastair J M Watson, Mark Tremelling, Miles Parkes, Severine Vermeire, Andreas Bender, Simon R Carding, Tamas Korcsmaros
A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis. Nature communications 13 (1) (2022)
Bram Verstockt, Nurulamin M Noor, Urko M Marigorta, Polychronis Pavlidis, Parakkal Deepak, Ryan C Ungaro, null null
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy. Journal of Crohn's & colitis 15 (9) (2022)
Bram Verstockt, Valery Volk, Charlot Jaeckel, Dahham Alsoud, João Sabino, Susanna Nikolaus, Marc Ferrante, Nicole Krönke, Friedrich Feuerhake, Gert De Hertogh, Philip Rosenstiel, Séverine Vermeire, Stefan Schreiber, Marc Ferrante, Konrad Aden
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis. Alimentary pharmacology & therapeutics 56 (2) (2022)
Huiwen Che, Tatjana Jatsenko, Lore Lannoo, Kate Stanley, Luc Dehaspe, Leen Vancoillie, Nathalie Brison, Ilse Parijs, Kris Van Den Bogaert, Koenraad Devriendt, Sabien Severi, Veerle Ide, Severine Vermeire, Bram Verstockt, Kristel Van Calsteren, Joris Robert Vermeesch
Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets. NPJ genomic medicine 7 (1) (2022)
Michael Todd Dolinger, Bram Verstockt
Ulcerative colitis, a transmural disease requiring an accurate IUS assessment in the current treat-to-target era. United European gastroenterology journal 10 (3) (2022)
Padhmanand Sudhakar, Judith Wellens, Bram Verstockt, Marc Ferrante, João Sabino, Severine Vermeire
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches? Gut (2022)
Bram Verstockt, Stefania Vetrano, Azucena Salas, Shadi Nayeri, Marjolijn Duijvestein, Niels Vande Casteele, null null
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease. Nature reviews. Gastroenterology & hepatology 19 (6) (2022)
Hussein Mahajna, Bram Verstockt, Daniel Bergemalm, Fabiana Castiglione, Fransisco Rodríguez-Moranta, Edoardo Vincenzo Savarino, Frank Hoentjen, Talat Bessissow, Jagoda Pokryszka, Anneline Cremer, Piotr Eder, Marie Truyens, Anat Yerushalmy-Feler, Maria Jose Garcia, Uri Kopylov
Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series. Journal of Crohn's & colitis (2022)
Dahham Alsoud, Bram Verstockt, Séverine Vermeire
Letter: immunogenicity is not the root cause for loss of response to anti-TNF agents in patients with IBD in TDM era. Alimentary pharmacology & therapeutics 55 (7) (2022)
Frank Phillips, Bram Verstockt, Malgorzata Sladek, Nanne de Boer, Konstantinos Katsanos, Konstantinos Karmiris, Ahmad Albshesh, Carl Erikson, Daniel Bergemalm, Tamas Molnar, Pierre Ellul, null null
Orofacial Granulomatosis associated with Crohn's Disease: a multi-centre case series. Journal of Crohn's & colitis (2021)
Nathalie Van den Berghe, Bram Verstockt, Ann Gils, João Sabino, Marc Ferrante, Séverine Vermeire, Paul J Declerck, Debby Thomas
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations. Journal of Crohn's & colitis 15 (6) (2021)
Timothy Raine, Stefanos Bonovas, Burisch J, Torsten Kucharzik, Michel Adamina, Vito Annese, Oliver Bachmann, Dominik Bettenworth, Maria Chaparro-Sanchez, Wladyslawa Czuber-Dochan, Piotr Eder, Pierre Ellul, Catarina Fidalgo, Gionata Fiorino, Paolo Gionchetti, Javier P Gisbert, Hannah Gordon, Charlotte Rose Hedin, Stefan D Holubar, Marietta Iacucci, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Peter Laszlo Lakatos, Theodore Lytras, Ivan Lyutakov, Nurulamin M Noor, Gianluca Pellino, Daniele Piovani, Edoardo Vincenzo Savarino, Francesco Selvaggi, Bram Verstockt, Antonino Spinelli, Yves Panis, Glen Doherty
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. Journal of Crohn's & colitis (2021)
Floris A E de Voogd, Bram Verstockt, Christian Maaser, Krisztina B Gecse
Point-of-care intestinal ultrasonography in inflammatory bowel disease. Nature reviews. Gastroenterology & hepatology 18 (4) (2021)
Antonino Spinelli, Stefanos Bonovas, Burisch J, Torsten Kucharzik, Michel Adamina, Vito Annese, Oliver Bachmann, Dominik Bettenworth, Maria Chaparro-Sanchez, Wladyslawa Czuber-Dochan, Piotr Eder, Pierre Ellul, Catarina Fidalgo, Gionata Fiorino, Paolo Gionchetti, Javier P Gisbert, Hannah Gordon, Charlotte Rose Hedin, Stefan D Holubar, Marietta Iacucci, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Peter Laszlo Lakatos, Theodore Lytras, Ivan Lyutakov, Nurulamin M Noor, Gianluca Pellino, Daniele Piovani, Edoardo Vincenzo Savarino, Francesco Selvaggi, Bram Verstockt, Glen Doherty, Timothy Raine, Yves Panis
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. Journal of Crohn's & colitis (2021)
T Kucharzik, P Ellul, T Greuter, J F Rahier, Bram Verstockt, C Abreu, A Albuquerque, M Allocca, M Esteve, F A Farraye, H Gordon, K Karmiris, U Kopylov, J Kirchgesner, E MacMahon, Fernando Magro, C Maaser, L de Ridder, Carlos Taxonera, M Toruner, L Tremblay, M Scharl, N Viget, Y Zabana, S Vavricka
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn's & colitis 15 (6) (2021)
Sare Verstockt, Bram Verstockt, Kathleen Machiels, Maaike Vancamelbeke, Marc Ferrante, Isabelle Cleynen, Gert De Hertogh, Séverine Vermeire
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease. Inflammatory bowel diseases 27 (10) (2021)
Frank Phillips, Bram Verstockt, Davide Giuseppe Ribaldone, Ivan Guerra, Niels Teich, Konstantinos Katsanos, Rafal Filip, Tamas Molnar, Konstantinos Karmiris
Diagnosis and outcome of extranodal primary intestinal lymphoma in inflammatory bowel disease: an ECCO CONFER case series. Journal of Crohn's & colitis (2021)
C Jorissen, Bram Verstockt, N Schils, João Sabino, Marc Ferrante, Severine Vermeire
Long-term clinical outcome after thiopurine discontinuation in elderly IBD patients. Scandinavian journal of gastroenterology 56 (11) (2021)
Ho-Su Lee, Maaike Vancamelbeke, Sare Verstockt, Tom Wilms, Bram Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire, Isabelle Cleynen
Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative Colitis. Cells 9 (8) (2020)
Nasim Sadat Seyed Tabib, Matthew Madgwick, Padhmanand Sudhakar, Bram Verstockt, Tamas Korcsmaros, Séverine Vermeire
Big data in IBD: big progress for clinical practice. Gut 69 (8) (2020)
Bram Verstockt, Marc Ferrante
Editorial: a clinical decision tool to identify patients who might benefit most from intensified dosing in the biological era-getting nearer? Alimentary pharmacology & therapeutics 51 (7) (2020)
Bram Verstockt, Séverine Vermeire, Marc Ferrante, Christine Breynaert
Editorial: biomarker predictors of non-response to TNFα antagonists - the quest continues. Authors' reply. Alimentary pharmacology & therapeutics 49 (8) (2020)
Bram Verstockt, M Van Hemelen, A Outtier, J Sabino, E Van Wijngaerden, P De Munter, M Ferrante, A Wilmer, S Vermeire
Invasive nocardiosis, disseminated varicella zoster reactivation, and pneumocystis jiroveci pneumonia associated with tofacitinib and concomitant systemic corticosteroid use in ulcerative colitis. Journal of gastroenterology and hepatology 35 (12) (2020)
Bram Verstockt, Liesbeth Boets, João Sabino, Séverine Vermeire, Marc Ferrante
Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn's disease. Gut 70 (7) (2020)
Vince B C Biemans, Bram Verstockt
Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease? United European gastroenterology journal 8 (7) (2020)
Sare Verstockt, Bram Verstockt, Severine Vermeire
Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD). Expert opinion on therapeutic targets 23 (11) (2019)
João Sabino, Bram Verstockt, Séverine Vermeire, Marc Ferrante
New biologics and small molecules in inflammatory bowel disease: an update. Therapeutic advances in gastroenterology 12 (2019)
Claire Liefferinckx, Bram Verstockt, Ann Gils, Sophie Tops, Wouter Van Moerkercke, Severine Vermeire, Denis Franchimont
Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases. United European gastroenterology journal 7 (6) (2019)
Bram Verstockt, Sare Verstockt, Brecht Creyns, Sophie Tops, Gert Van Assche, Ann Gils, Jan L Ceuppens, Séverine Vermeire, Marc Ferrante, Christine Breynaert
Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease. Alimentary pharmacology & therapeutics 49 (5) (2019)
Bram Verstockt, Charlotte Claeys, Gert De Hertogh, Gert Van Assche, Albert Wolthuis, André D'Hoore, Séverine Vermeire, Marc Ferrante
Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience. United European gastroenterology journal 7 (9) (2019)
Bram Verstockt, Sare Verstockt, Helene Blevi, Isabelle Cleynen, Magali de Bruyn, Gert Van Assche, Séverine Vermeire, Marc Ferrante
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients? Gut 68 (8) (2018)
Bram Verstockt, Gitte Moors, Sumin Bian, Thomas Van Stappen, Gert Van Assche, Severine Vermeire, Ann Gils, Marc Ferrante
Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing. Alimentary pharmacology & therapeutics 48 (7) (2018)
Bram Verstockt, Severine Vermeire, Gert Van Assche, Marc Ferrante
When IBD is not IBD. Scandinavian journal of gastroenterology 53 (9) (2018)
Bram Verstockt, Barbara Deleenheer, Gert Van Assche, Severine Vermeire, Marc Ferrante
A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases. Expert opinion on drug safety 16 (7) (2017)

Bram Verstockt.css-eqlu8i{font-size:small;padding-left:4px;} (B Verstockt)

Publication Activity (10 Years)

Top Topics

Top Venues

Bram Verstockt (B Verstockt)